Volpara share price charges higher on ScreenPoint distribution agreement news

The Volpara Health Technologies Ltd (ASX:VHT) share price has charged higher this morning after announcing a potentially lucrative distribution deal…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

In morning trade the Volpara Health Technologies Ltd (ASX: VHT) share price has charged higher following the announcement of a new sales agreement.

At the time of writing the medical technology company's shares are up 4% to $3.69.

What did Volpara announce?

This morning Volpara announced that it has entered into a full distribution agreement with artificial intelligence software company ScreenPoint Medical BV.

According to the release, the five-year, non-exclusive contract will see Volpara selling ScreenPoint's Transpara software via its established direct sales force throughout Australia, New Zealand, the United States, and parts of Asia.

What is Transpara?

The release explains that Transpara is next-generation computer-aided detection software designed to help radiologists read screening mammograms by marking specific areas of the breast image as likely being cancer or not.

Breast cancers can be missed or masked in a breast image for several reasons. These include breast density, poor image quality, the radiologist not seeing the cancer, and the radiologist misinterpreting the cancer's appearance.

However, management believes that combining both the Volpara and Transpara solutions will optimise the early detection of breast cancer, thereby reducing radiologist liability and risk. It also expects their combined use to cut screening costs by potentially eliminating a reader in systems that deploy double-reading mammography.

Volpara's CEO, Dr Ralph Highnam, believes the ScreenPoint distribution agreement is significant because it enriches Volpara's offering to breast imaging centres.

He explained: "Critically, it helps expand the software toolkit that our sales people can sell and increases potential ARPU still further beyond the Volpara and MRS products. Based on the clinical papers to date, we're sure that Transpara is world leading and will be very successful commercially, especially when it achieves its US clearance from the Food and Drug Administration (FDA) for 3D breast images."

In respect to its average revenue per user (ARPU), following the acquisition of MRS Systems and the ScreenPoint distribution deal, management believes the Volpara sales force can now sell a full set of products which potentially could generate up to US$10 of ARPU from breast imaging clinics.

As a comparison, in FY 2019 the average price per woman screened in the US for the base Volpara Enterprise product was US$2.17.

Elsewhere in the industry on Monday, Ellex Medical Lasers Ltd (ASX: ELX) and Somnomed Limited (ASX: SOM) shares could storm higher after the release of positive announcements this morning.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended VOLPARA FPO NZ. The Motley Fool Australia owns shares of Ellex Medical Lasers Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

A young male ASX investor raises his clenched fists in excitement because of rising ASX share prices today
Share Gainers

3 ASX All Ords shares up 50%+ in March

These ASX shares have been on fire this month. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Share Gainers

Why Mesoblast, Patriot Battery Metals, Sigma, and Zip shares are pushing higher

These shares are having a good session on hump day. But why?

Read more »

Woman looks amazed and shocked as she looks at her laptop.
Consumer Staples & Discretionary Shares

If you'd put $20,000 in this ASX retail stock at the start of 2023, you'd have $134,000 now

This online retailer has executed a remarkable turnaround for its investors.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to earth for ASX shares this Tuesday.

Read more »